FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Granules Pharmaceuticals' lisdexamfetamine dimesylate as a generic drug (Original Application) with indications for attention-deficit/hyperactivity…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Binge Eating Disorder

Drugs mentioned

• LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)